Table 1 Demographics for the microarray study

From: Implication of the glutamate–cystine antiporter xCT in schizophrenia cases linked to impaired GSH synthesis

 

Patients

Controls

GCLC

Low-risk

High-risk

Low-risk

High-risk

n =

10

10

15

5

Age in years (s.d)

30.3 (2.2)

36.7 (4)

38.9 (2.3)

28.8 (2.7)

Sex (males/females)

6 / 4

7 / 3

9 / 6

2 / 3

Diagnostic

    

Schizophrenia

9

6

–

–

Schizo-affective

–

2

–

–

Schizotype

1

1

–

–

Medication in CPZ

80 (20)

79 (44)

–

–

  1. s.d. standard deviation
Back to article page